We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$5.8B
AUM Growth
-$877M
Cap. Flow
-$1.07B
Cap. Flow %
-18.41%
Top 10 Hldgs %
67.63%
Holding
285
New
60
Increased
42
Reduced
77
Closed
80

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$31.9M
2
GEHC icon
GE HealthCare
GEHC
+$31.5M
3
IBRX icon
ImmunityBio
IBRX
+$20.9M
4
GTLB icon
GitLab
GTLB
+$14.8M
5
VSTM icon
Verastem
VSTM
+$13.4M

Top Sells

Rank Stock Value
1
EXAS
Exact Sciences
EXAS
+$52.3M
2
SPB icon
Spectrum Brands
SPB
+$49.4M
3
SMPL icon
Simply Good Foods
SMPL
+$46.6M
4
SAM icon
Boston Beer
SAM
+$42M
5
DPZ icon
Domino's
DPZ
+$41.4M

Sector Composition

Rank Sector Weight
1 Healthcare 31.42%
2 Consumer Discretionary 5.85%
3 Technology 4.99%
4 Consumer Staples 1.48%
5 Communication Services 1.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRCA icon
101
Verrica Pharmaceuticals
VRCA
$88.8M
$4.71M 0.08%
888,134
+31,394
+4% +$169K
INGN icon
102
Inogen
INGN
$180M
$4.67M 0.08%
+664,000
New +$4.47M
ARAY icon
103
Accuray
ARAY
$31.6M
$4.43M 0.08%
3,236,000
+700,000
+28% +$1.04M
LEN icon
104
Lennar Class A
LEN
$20.3B
$4.43M 0.08%
40,021
+5,021
+14% +$544K
SHW icon
105
Sherwin-Williams
SHW
$85B
$4.29M 0.07%
12,500
-1,518
-11% -$526K
RH icon
106
RH
RH
$3.24B
$4.21M 0.07%
22,292
-50,274
-69% -$9.34M
WYNN icon
107
Wynn Resorts
WYNN
$10.1B
$4.2M 0.07%
+44,857
New +$3.81M
ARVN icon
108
Arvinas
ARVN
$516M
$4.12M 0.07%
+560,000
New +$4.12M
DECK icon
109
Deckers Outdoor
DECK
$13.5B
$3.97M 0.07%
38,516
-42,970
-53% -$4.76M
AS icon
110
Amer Sports
AS
$21.1B
$3.93M 0.07%
101,309
-7,685
-7% -$236K
ANRO icon
111
Alto Neuroscience
ANRO
$1.05B
$3.57M 0.06%
1,624,000
+24,000
+2% +$57.1K
LEVI icon
112
Levi Strauss
LEVI
$9.43B
$3.51M 0.06%
190,000
-30,000
-14% -$499K
BBY icon
113
Best Buy
BBY
$17.7B
$3.31M 0.06%
49,373
-22,771
-32% -$1.55M
AZN icon
114
AstraZeneca
AZN
$243B
$3.28M 0.06%
23,500
+11,500
+96% +$1.61M
MOBX icon
115
Mobix Labs
MOBX
$25.8M
$3.27M 0.06%
+427,600
New +$3.18M
GKOS icon
116
Glaukos
GKOS
$10.1B
$3.25M 0.06%
+31,438
New +$2.95M
NKTR icon
117
Nektar Therapeutics
NKTR
$2.35B
$3.2M 0.06%
124,000
+54,933
+80% +$617K
VERA icon
118
Vera Therapeutics
VERA
$2.3B
$3.2M 0.06%
136,000
-164,000
-55% -$3.69M
LLY icon
119
Eli Lilly
LLY
$998B
$3.04M 0.05%
3,898
+3,583
+1,137% +$2.78M
PDSB icon
120
PDS Biotechnology
PDSB
$39.1M
$2.97M 0.05%
2,236,000
-2,183,000
-49% -$2.96M
AVPT icon
121
AvePoint
AVPT
$2.84B
$2.9M 0.05%
+150,000
New +$2.6M
VSXY
122
Victoria's Secret
VSXY
$7B
$2.87M 0.05%
155,000
+35,000
+29% +$684K
LIVN icon
123
LivaNova
LIVN
$4.47B
$2.75M 0.05%
+61,000
New +$2.52M
CROX icon
124
Crocs
CROX
$6.42B
$2.6M 0.04%
+25,685
New +$2.62M
SYRE icon
125
Spyre Therapeutics
SYRE
$8.3B
$2.57M 0.04%
172,000
-28,000
-14% -$414K
3 4
5
6 7

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Armistice Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Armistice Capital held 285 positions worth $5.8B, down 13% from $6.67B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Armistice Capital withdrew a net $1.07B in Q2 2025, closing 80 positions and reducing 77 holdings. Its most notable exit was Spectrum Brands, an estimated $49.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Armistice Capital opened a new position in ImmunityBio worth $20.5M.

  • Armistice Capital's largest Q2 2025 buy was ImmunityBio: 7,764,000 shares worth $20.5M.
  • Armistice Capital added most to McDonald's in Q2 2025, an estimated $31.9M increase.
  • Armistice Capital's biggest Q2 2025 reduction was Exact Sciences, cutting an estimated $52.3M.
  • Armistice Capital fully exited Spectrum Brands in Q2 2025, selling an estimated $49.4M.
  • Armistice Capital's ten largest holdings make up 68% of its $5.8B portfolio in Q2 2025.
  • Armistice Capital opened 60 new positions and closed 80 in Q2 2025.
  • Armistice Capital's portfolio value fell 13% quarter-over-quarter to $5.8B.

Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.